IQVIA Holdings Inc. (LON:0JDM)
London
· Delayed Price · Currency is GBP · Price in USD | Market Cap | 26.61B |
| Revenue (ttm) | 12.31B |
| Net Income (ttm) | 1.10B |
| Shares Out | n/a |
| EPS (ttm) | 5.98 |
| PE Ratio | 24.27 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 24 |
| Average Volume | 789 |
| Open | 193.28 |
| Previous Close | 194.40 |
| Day's Range | 191.96 - 193.74 |
| 52-Week Range | 166.94 - 261.42 |
| Beta | n/a |
| RSI | 37.00 |
| Earnings Date | Feb 13, 2025 |
About IQVIA Holdings
IQVIA Holdings Inc. provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to ... [Read more]
Financial Performance
In 2024, IQVIA Holdings's revenue was $15.41 billion, an increase of 2.81% compared to the previous year's $14.98 billion. Earnings were $1.37 billion, an increase of 1.10%.
Financial numbers in USD Financial StatementsNews
IQVIA Releases 2024 Sustainability Report
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healt...
IQVIA: Revenues, Net Profit Margin, And A Positive Long-Term Outlook Will Pave The Way
IQVIA has seen an increase of 58.97% in its revenues since 2017. In addition, its net profit margin has strengthened since 2018. The CRO market expects to grow at a 7.42% CAGR between 2024 and 2033, w...
IQVIA Holdings Inc. 2024 Q4 - Results - Earnings Call Presentation
The following slide deck was published by IQVIA Holdings Inc.
IQVIA Holdings Inc. (IQV) Q4 2024 Earnings Call Transcript
IQVIA Delivers Solid Q4 Growth Despite 'Choppy' Market Conditions
On Thursday, IQVIA Holdings Inc (NYSE: IQV) reported a fourth adjusted EPS of $3.12, up from $2.84, beating the consensus of $3.11 . Provider of advanced analytics reported sales of $3.96 billion, al...
IQVIA Delivers Solid Q4 Growth Despite 'Choppy' Market Conditions
On Thursday, IQVIA Holdings Inc IQV reported a fourth adjusted EPS of $3.12, up from $2.84, beating the consensus of $3.11.
IQVIA beats quarterly results estimates on analytics services demand
Contract research firm IQVIA Holdings beat Wall Street estimates for fourth-quarter profit and revenue on Thursday, helped by the demand for its healthcare data and analytics services.
IQVIA Holdings Inc (IQV) Q4 Earnings: EPS of $2.42 Beats Estimate, Revenue Hits $3,958 Million
IQVIA Holdings Inc (IQV) Q4 Earnings: EPS of $2.42 Beats Estimate, Revenue Hits $3,958 Million
IQVIA Reports Fourth-Quarter and Full-Year 2024 Results; Reaffirms Full-Year 2025 Guidance
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the...
IQVIA named to the Fortune® World's Most Admired Companies™ list, ranked No. 1 in its sector for fourth consecutive year
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence, was named No. 1 in its catego...
IQVIA to Announce Fourth-Quarter and Full-Year 2024 Results on February 6, 2025
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) will announce its fourth-quarter and full-year 2024 financial results before the market opens on Thursday, Febru...
IQVIA and NVIDIA Collaborate to Transform Healthcare and Life Sciences Through Advanced Agentic AI Solutions
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights, and healthcare intelligence, today announced a strategic ...
How Is The Market Feeling About IQVIA Hldgs?
IQVIA Hldgs's (NYSE: IQV) short percent of float has fallen 9.69% since its last report. The company recently reported that it has 2.81 million shares sold short , which is 1.77% of all regular share...
IQVIA Holdings Inc (IQV) Unveils Latest Digital Health Trends Report
IQVIA Holdings Inc (IQV) Unveils Latest Digital Health Trends Report
Digital Health Tools are Expanding in Scope and Function to Aid Patient Diagnosis, Treatment and Monitoring, Says New Report from The IQVIA Institute
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Despite a drop in venture funding for digital health companies over the last two-and-a-half years, digital health products and solutions are expanding in...
IQVIA Holdings: Share Price Disconnected From Growth Outlook
IQVIA CFO Ron Bruehlman to Speak at the UBS Global Healthcare Conference on November 13, 2024
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) announced today that Ron Bruehlman, executive vice president and chief financial officer, will speak at the UBS ...
IQVIA Holdings Inc. (IQV) Q3 2024 Earnings Call Transcript
IQVIA Holdings Inc. (NYSE:IQV) Q3 2024 Results Conference Call October 31, 2024 9:00 AM ET Company Participants Kerri Joseph - Senior Vice President, Investor Relations & Treasury Ari Bousbib - Chair...
IQVIA lowers annual revenue forecast amid trial delays
Contract research firm IQVIA lowered its annual revenue forecast on Thursday, due to delays in two clinical trials as one of its clients faces logistical challenges.
IQVIA Reports Third-Quarter 2024 Results and Announces Investor Day
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the...
IQVIA to Announce Third-Quarter 2024 Results on October 31, 2024
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) will announce its third-quarter 2024 financial results before the market opens on Thursday, October 31, 2024. Th...
IQVIA Announces IQVIA AI Assistant, Powered by IQVIA Healthcare-grade AI™
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healt...
IQVIA AI Solution Receives 2024 Frost & Sullivan Global Customer Value Leadership Award
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA™ (NYSE:IQV), a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry, to...
Contract Research Giant IQVIA's Data Assets Are Biggest Differentiator, Provides Best Exposure To AI And Data Opportunities: Analyst
RBC Capital Markets initiated coverage on IQVIA Holdings Inc. IQV, noting the company's biggest differentiator is its data assets. The analyst says IQVIA is the largest global contract research organi...
Signant Health expands availability of its eClinical solutions by joining IQVIA One Home for Sites initiative
PHILADELPHIA , Sept. 4, 2024 /PRNewswire/ -- Signant Health, the leader in evidence generation for modern clinical trials, announced today it has joined IQVIA, a leading global provider of advanced an...